Cargando…

Effect of ACE-inhibition on coronary microvascular function and symptoms in normotensive women with microvascular angina: A randomized placebo-controlled trial

OBJECTIVE: Studies have suggested a beneficial effect of angiotensin-converting enzyme (ACE) inhibition. To explore whether the ACE inhibitor ramipril has a direct effect on the microvasculature beyond the blood pressure (BP) lowering effect, we investigated whether ramipril improved coronary microv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michelsen, Marie Mide, Rask, Anna Bay, Suhrs, Elena, Raft, Kristoffer Flintholm, Høst, Nis, Prescott, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993253/ https://www.ncbi.nlm.nih.gov/pubmed/29883497 http://dx.doi.org/10.1371/journal.pone.0196962

Ejemplares similares

Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study
por: Mygind, Naja Dam, et al.
Publicado: (2016)

Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction
por: Schroder, Jakob, et al.
Publicado: (2019)

Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study
por: Mygind, Naja Dam, et al.
Publicado: (2016)

Overlap between angina without obstructive coronary artery disease and left ventricular diastolic dysfunction with preserved ejection fraction
por: Michelsen, Marie Mide, et al.
Publicado: (2019)

Comprehensive treatment of microvascular angina in overweight women – a randomized controlled pilot trial
por: Bove, Kira Bang, et al.
Publicado: (2020)

Inflammation, non-endothelial dependent coronary microvascular function and diastolic function—Are they linked?
por: Suhrs, Hannah E., et al.
Publicado: (2020)

Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study
por: Suhrs, Hannah Elena, et al.
Publicado: (2022)

Doppler Echocardiography Assessment of Coronary Microvascular Function in Patients With Angina and No Obstructive Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2021)

Systemic microvascular dysfunction in microvascular and vasospastic angina
por: Ford, Thomas J, et al.
Publicado: (2018)

Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms
por: Bove, Kira Bang, et al.
Publicado: (2021)

Coronary Microvascular Angina: A State-of-the-Art Review
por: Spione, Francesco, et al.
Publicado: (2022)

Microvascular angina: angina that predominantly affects women
por: Park, Jin Joo, et al.
Publicado: (2015)

Coronary Venous Pressure and Microvascular Hemodynamics in Patients With Microvascular Angina: A Randomized Clinical Trial
por: Ullrich, Helen, et al.
Publicado: (2023)

Microvascular Angina: Diagnosis and Management
por: Aldiwani, Haider, et al.
Publicado: (2021)

Physiological Stratification of Patients With Angina Due to Coronary Microvascular Dysfunction
por: Rahman, Haseeb, et al.
Publicado: (2020)

Angina due to obstructive coronary artery disease and microvascular dysfunction
por: Crea, Filippo
Publicado: (2019)

Vasodilator Strain Stress Echocardiography in Suspected Coronary Microvascular Angina
por: Rodriguez-Zanella, Hugo, et al.
Publicado: (2022)

Non-pharmacological Treatment of Refractory Angina and Microvascular Angina
por: Rakhimov, Kudrat, et al.
Publicado: (2020)

The effect of DPP-4-protected GLP-1 (7–36) on coronary microvascular function in obese adults
por: Nilsson, Malin, et al.
Publicado: (2019)

Updates on Pharmacologic Management of Microvascular Angina
por: Soleymani, Mosayeb, et al.
Publicado: (2022)

Effect of Proprietary Chinese Medicine on Coronary Microvascular Dysfunction in Patients with Microvascular Angina: A Systematic Review and Meta-Analysis
por: Yu, Qiuyu, et al.
Publicado: (2023)

Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary Arteries
por: Dutta, Utkarsh, et al.
Publicado: (2022)

Increased levels of angiogenic factors in microvascular angina
por: Asl, Elmira Roshani, et al.
Publicado: (2019)

COVID-19 persistente y angina microvascular
por: Vallejo Camazón, Nuria, et al.
Publicado: (2022)

Doppler Versus Thermodilution-Derived Coronary Microvascular Resistance to Predict Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction or Stable Angina Pectoris
por: Williams, Rupert P., et al.
Publicado: (2018)

An Unusual Case of Suspected Microvascular Angina in a Newborn
por: Cataldo, Stefania, et al.
Publicado: (2012)

Diagnosis of Microvascular Angina Using Cardiac Magnetic Resonance
por: Liu, Alexander, et al.
Publicado: (2018)

Angina due to microvascular dysfunction with severe heart failure
por: Marzilli, Mario
Publicado: (2019)

Angina due to microvascular dysfunction and atrioventricular conduction defects
por: Lopatin, Yury
Publicado: (2019)

Long COVID-19 and microvascular disease-related angina
por: Vallejo Camazón, Nuria, et al.
Publicado: (2022)

Prevalence of microvascular angina among patients with stable symptoms in the absence of obstructive coronary artery disease: a systematic review
por: Aribas, Elif, et al.
Publicado: (2021)

Microvascular Myocardial Ischemia in Patients With Diabetes Without Obstructive Coronary Stenosis and Its Association With Angina
por: Yu, Yarong, et al.
Publicado: (2023)

International prospective cohort study of microvascular angina – Rationale and design
por: Suda, Akira, et al.
Publicado: (2020)

The Central Nervous System and Psychosocial Factors in Primary Microvascular Angina
por: Cattaneo, Mattia, et al.
Publicado: (2022)

Refractory microvascular angina in hypertrophic cardiomyopathy: a novel therapy?
por: Cheng, Kevin, et al.
Publicado: (2022)

Coronary Microvascular Dysfunction
por: Vancheri, Federico, et al.
Publicado: (2020)

Coronary Microvascular Disease
por: Thakker, Ravi A., et al.
Publicado: (2022)

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
por: Bairey Merz, C. Noel, et al.
Publicado: (2016)

Coronary Microvascular Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Artery Disease Is Associated With Elevated Serum Homocysteine Levels
por: Ahmad, Ali, et al.
Publicado: (2020)

Optimal Use of Vasodilators for Diagnosis of Microvascular Angina in the Cardiac Catheterization Laboratory
por: Rahman, Haseeb, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_isnj1k792714i1j3h5972gs0lm